bayer

Bayer's $2.9bn bid wins Norway cancer firm

Norwegian cancer treatment specialist Algeta has agreed to a 1.9 billion euro ($2.9bn) takeover from Germany's Bayer, after the pharmaceuticals giant sweetened its bid, offering 363 kroner per share in cash.